Hidehito Horinouchi Selected Research

Death Domain Receptors

1/2021

Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidehito Horinouchi Research Topics

Disease

89	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 08/2008
57	Neoplasms (Cancer) 05/2024 - 08/2011
15	Lung Neoplasms (Lung Cancer) 06/2023 - 07/2011
13	Disease Progression 09/2023 - 01/2015
11	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 09/2009
10	Thymoma (Thymic Carcinoma) 10/2023 - 08/2011
8	Neutropenia 01/2023 - 08/2008
6	Neoplasm Metastasis (Metastasis) 07/2023 - 04/2013
6	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 04/2013
5	Pneumonia (Pneumonitis) 10/2023 - 09/2009
5	Carcinoma (Carcinomatosis) 01/2022 - 07/2011
5	Adenocarcinoma of Lung 11/2021 - 04/2012
4	Leukopenia 01/2020 - 07/2014
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 12/2016
3	Exanthema (Rash) 01/2023 - 01/2017
3	Thrombocytopenia (Thrombopenia) 01/2020 - 07/2014
2	Cachexia 01/2023 - 02/2022
2	Diarrhea 01/2023 - 01/2017
2	Idiopathic Pulmonary Fibrosis 12/2022 - 01/2018
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2020 - 01/2019
2	Anemia 01/2020 - 11/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 02/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 12/2016
2	Brain Neoplasms (Brain Tumor) 04/2013 - 04/2012
1	Dysbiosis 04/2024
1	Central Nervous System Diseases (CNS Diseases) 04/2024
1	Hypersensitivity (Allergy) 01/2023
1	Genomic Instability 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2023

Drug/Important Bio-Agent (IBA)

17	NivolumabIBA 01/2024 - 10/2018
17	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2012
16	pembrolizumabIBA 04/2024 - 12/2020
14	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2012
12	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2015
11	Immune Checkpoint InhibitorsIBA 07/2023 - 03/2016
11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2012
11	B7-H1 AntigenIBA 11/2022 - 05/2015
10	PlatinumIBA 04/2024 - 04/2012
8	LigandsIBA 12/2023 - 05/2015
8	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 08/2011
6	Monoclonal AntibodiesIBA 10/2023 - 06/2015
6	Gefitinib (Iressa)FDA Link 01/2023 - 04/2013
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 04/2013
5	CrizotinibIBA 05/2024 - 08/2016
5	Pemetrexed (MTA)FDA Link 08/2023 - 04/2013
5	Alanine Transaminase (SGPT)IBA 01/2023 - 11/2015
5	Docetaxel (Taxotere)FDA Link 01/2023 - 10/2018
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 08/2011
4	alectinibIBA 04/2024 - 01/2017
4	Programmed Cell Death 1 ReceptorIBA 10/2023 - 10/2018
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 11/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 07/2014
3	Phosphotransferases (Kinase)IBA 05/2024 - 07/2014
3	IpilimumabIBA 01/2024 - 08/2015
3	durvalumabIBA 10/2023 - 01/2022
3	Anaplastic Lymphoma KinaseIBA 07/2023 - 01/2017
3	osimertinibIBA 06/2023 - 07/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2016
3	RamucirumabIBA 01/2023 - 01/2019
3	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2017
3	nintedanibIBA 12/2022 - 01/2018
3	SolutionsIBA 03/2022 - 01/2018
3	amrubicinIBA 11/2019 - 07/2011
3	Vinorelbine (Navelbine)FDA LinkGeneric 08/2013 - 02/2012
2	Tyrosine (L-Tyrosine)FDA Link 05/2024 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 09/2009
2	AntibodiesIBA 04/2024 - 01/2023
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2017
2	Cell-Free Nucleic AcidsIBA 11/2022 - 02/2016
2	Antineoplastic Agents (Antineoplastics)IBA 07/2022 - 07/2022
2	EnzymesIBA 04/2022 - 10/2018
2	AntiemeticsIBA 04/2022 - 05/2020
2	CytokinesIBA 02/2022 - 01/2022
2	ceritinibIBA 09/2018 - 01/2017
2	patritumabIBA 12/2016 - 06/2015
2	linifanibIBA 02/2016 - 07/2014
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2016 - 07/2014
1	Adenosine Triphosphate (ATP)IBA 05/2024
1	AntigensIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	NF-kappa B (NF-kB)IBA 10/2023
1	Formaldehyde (Formol)FDA Link 08/2023
1	ParaffinIBA 08/2023
1	pegylated granulocyte colony-stimulating factorIBA 01/2023
1	eribulin FDA Link 01/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	HeterochromatinIBA 01/2023
1	Cytochrome P-450 CYP3AIBA 04/2022

Therapy/Procedure

40	Drug Therapy (Chemotherapy) 04/2024 - 09/2009
38	Therapeutics 10/2023 - 08/2008
13	Chemoradiotherapy 10/2023 - 01/2012
10	Radiotherapy 02/2023 - 01/2012
5	Immunotherapy 04/2024 - 05/2015
4	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 08/2008
3	Molecular Targeted Therapy 10/2022 - 12/2015
2	Neoadjuvant Therapy 01/2022 - 01/2020
1	Precision Medicine 06/2023
1	Surgical Instruments (Clip) 06/2023
1	Retreatment 01/2023